Mannkind (MNKD) FCF Margin (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.00 |
| Dec 31, 2025 | -3,647.00 |
| Sep 30, 2025 | 1,931.00 |
| Jun 30, 2025 | 1,880.00 |
| Mar 31, 2025 | -2,736.00 |
| Dec 31, 2024 | -7.00 |
| Sep 30, 2024 | 1,871.00 |
| Jun 30, 2024 | -743.00 |
| Mar 31, 2024 | -3,084.00 |
| Dec 31, 2023 | -2,273.00 |
| Sep 30, 2023 | 10,262.00 |
| Jun 30, 2023 | -3,829.00 |
| Mar 31, 2023 | 2,051.00 |
| Dec 31, 2022 | 5,946.00 |
| Sep 30, 2022 | 963,288.00 |
| Jun 30, 2022 | -952,167.00 |
| Mar 31, 2022 | -13,572.00 |
| Dec 31, 2021 | 3,268.00 |
| Sep 30, 2021 | 172.00 |
| Jun 30, 2021 | -1,440.00 |
| Mar 31, 2021 | -7,719.00 |
| Dec 31, 2020 | 8,628.00 |
| Sep 30, 2020 | 188,830.00 |
| Jun 30, 2020 | -190,670.00 |
| Mar 31, 2020 | -2,260.00 |
| Dec 31, 2019 | 730,530.00 |
| Sep 30, 2019 | 277,250.00 |
| Jun 30, 2019 | -1.01 Mn |
| Mar 31, 2019 | -22,388.00 |
| Dec 31, 2018 | 46,733.00 |
| Sep 30, 2018 | 38,595.00 |
| Jun 30, 2018 | -7,259.00 |
| Mar 31, 2018 | 3,701.00 |
| Dec 31, 2017 | 47,718.00 |
| Sep 30, 2017 | -21,280.00 |
| Jun 30, 2017 | -120,893.00 |
| Mar 31, 2017 | 38,552.00 |
| Dec 31, 2016 | -8,860.00 |